Mielke, Nina http://orcid.org/0000-0002-8951-9823
Barghouth, Muhammad Helmi http://orcid.org/0000-0002-5721-9367
Fietz, Anne-Katrin http://orcid.org/0000-0002-4395-4176
Villain, Cédric http://orcid.org/0000-0002-2050-2767
Bothe, Tim http://orcid.org/0000-0003-4404-2379
Ebert, Natalie http://orcid.org/0000-0002-4463-3315
Schaeffner, Elke http://orcid.org/0000-0002-7925-4577
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 8 November 2023
Accepted: 12 March 2024
First Online: 12 April 2024
Declarations
:
: The study was approved by the ethics committee, Charité - Universitätsmedizin Berlin, Germany (EA2/009/08), and is in accordance with the 1964 Helsinki declaration and its later amendments. Written informed consent was obtained from all individual participants included in the study.
: Not applicable.
: NE received consultancy fees from Bayer AG Leverkusen. ES received grant money from Bayer and consultancy fees from Astra Zeneca. She also receives personal fees from the National Kidney Foundation for editorial work for the American Journal of Kidney Diseases.